“On May 22, 2023, Janssen Biotech, Inc. requested the voluntary withdrawal of the emergency use authorization (EUA) of the Janssen COVID-19 Vaccine,” the FDA website states. “Janssen Biotech, Inc. informed the FDA that the last lots of the vaccine purchased by the U.S. Government have expired, there is no demand for new lots of the vaccine in the U.S., and they do not intend to update the strain composition of this vaccine to address emerging variants. On June 1, 2023, FDA revoked the EUA for this vaccine.”

While J&J’s EUA was officially withdrawn because all the available doses in the U.S. have expired and the pharma giant decided to discontinue the product, the FDA and others have raised concerns about the safety of the J&J injection in the past.

[It’s been a rocky road for J&J. I doubt this will be an end to it, either. — Ed]